Supplements
Supplement: Keys to success with today’s presbyopia and toric lens technologies
Conducted for the sixth time at the 39th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), the 2020 ESCRS Clinical Trends Survey comprised 145 questions and received responses from nearly 400 doctors. In terms of trends in the use of intraocular lenses (IOLs) in routine practice, survey responses suggested that implantation of presbyopia-correcting IOLs during cataract surgery has remained stable over the past five years. However, in the same period, the use of toric IOLs during cataract procedures has doubled from 7% to 14% (Figure 1). Interestingly, survey respondents reported that if ‘cost were not an issue’, 38% of patients with clinically significant astigmatism would receive a toric IOL. In regions where reimbursement is available for toric IOLs, such as Australia, the reported use of these lenses is much greater (60–70%).
Tags: presbyopia and toric lens
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.